 |
 |
 |
 |
 |
|
IRB Services Ethical Review of Research 1. Full Board Review The Sterling Board meets twice per week (typically on Tuesdays and Thursdays) to review the ethical considerations associated with new and continuing research studies. Please see the Board Meeting Calendar for specific meeting dates. New studies and changes in Sterling IRB-approved research that affect participant risk should be submitted by mail, email or fax and received by Sterling IRB at least 5 business days prior to the meeting. |
|
|
| Please note: The Sterling IRB administrative staff works closely with clients to meet deadlines, particularly those that do not fall within the usual study submission timeline. The staff makes every effort to resolve any questions or concerns prior to the Board meeting to ensure timely approval. | ||
Sterling IRB will typically contact the Sponsor/CRO and/or Principal Investigator within 24 to 48 hours of the meeting with notification of the Board’s decision. Approval documents will usually be sent within 2 business days. 2. Expedited Review Pursuant to US Food and Drug Administration (FDA) regulations and US Department of Health and Human Services (DHHS) regulations, Sterling IRB employs the expedited review procedure for minor changes in previously approved research during the period (of 1 year or less) for which approval is authorized, and for initial review of studies in permissible categories as detailed in the Federal Register. The investigator, Sponsor, and any other institutional bodies will be notified in writing of the Board's determination. Approval documents will usually be sent within 2 business days of approval. To learn more or if you have any questions, call 1-888-636-1062 (toll-free) or email us. |
|